0001104659-20-111774.txt : 20201002 0001104659-20-111774.hdr.sgml : 20201002 20201002171912 ACCESSION NUMBER: 0001104659-20-111774 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20201002 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201002 DATE AS OF CHANGE: 20201002 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Axovant Gene Therapies Ltd. CENTRAL INDEX KEY: 0001636050 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981333697 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37418 FILM NUMBER: 201221231 BUSINESS ADDRESS: STREET 1: 11-12 ST. JAMES'S SQUARE STREET 2: SUITE 1, 3RD FLOOR CITY: LONDON STATE: X0 ZIP: SW1Y 4LB BUSINESS PHONE: 44 203 318 9708 MAIL ADDRESS: STREET 1: 11 TIMES SQUARE STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Axovant Sciences Ltd. DATE OF NAME CHANGE: 20150324 FORMER COMPANY: FORMER CONFORMED NAME: Axovant Sciences, Inc. DATE OF NAME CHANGE: 20150324 FORMER COMPANY: FORMER CONFORMED NAME: Roivant Neurosciences Ltd. DATE OF NAME CHANGE: 20150309 8-K 1 tm2031140d2_8k.htm FORM 8-K
0001636050 false 0001636050 2020-10-01 2020-10-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

Current report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 2, 2020

 

Axovant Gene Therapies Ltd.

(Exact name of registrant as specified in its charter)

 

Bermuda 001-37418 98-1333697
(State or other jurisdiction of
incorporation)
(Commission File No.) (I.R.S. Employer Identification No.)

 

Suite 1, 3rd Floor

11-12 St. James’s Square

London, United Kingdom

SW1Y 4LB
(Address of principal executive office) (Zip Code)

 


Registrant’s telephone number, including area code: +44 203 997 8931
 
 
(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
     

Common Shares, $0.00001 par value per share

AXGT The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

 

 

 

 

 

 

 

Item 8.01 Other Events.

 

Axovant Gene Therapies Ltd. previously entered into a sales agreement, or the Sales Agreement, on June 11, 2020, with SVB Leerink LLC, or SVB Leerink, to sell common shares from time to time through an “at-the-market” equity offering program under which SVB Leerink acts as our agent. We previously issued and sold approximately 6.2 million common shares for approximately $19.7 million in net proceeds under the Sales Agreement. On the date hereof, we filed a prospectus supplement, or the Prospectus Supplement, with the Securities and Exchange Commission, or the SEC, to sell additional common shares under the Sales Agreement having an aggregate offering price of up to $50,000,000.

 

Under the Sales Agreement, we will set the parameters for the sale of our common shares, including the number of common shares to be issued, the time period during which sales are requested to be made, limitation on the number of common shares that may be sold in any one trading day and any minimum price below which sales may not be made. Subject to the terms and conditions of the Sales Agreement, SVB Leerink may sell our common shares by any method deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, including, without limitation, sales made through The Nasdaq Global Select Market, or the Nasdaq, or on any other existing trading market for our common shares. SVB Leerink will use commercially reasonable efforts in conducting such sales activities consistent with its normal trading and sales practices, applicable state and federal laws, rules and regulations and the rules of the Nasdaq. The Sales Agreement may be terminated by us upon five days’ notice to SVB Leerink for any reason or by SVB Leerink upon five days’ notice to us for any reason or at any time under certain circumstances, including but not limited to the occurrence of a material adverse change in us. Under the terms of the Sales Agreement, we may also sell common shares to SVB Leerink acting as principal for SVB Leerink’s own account at prices agreed upon at the time of sale.

 

The Sales Agreement provides that SVB Leerink will be entitled to compensation for its services in an amount equal to 3% of the gross proceeds of any common shares sold under the Sales Agreement. We have no obligation to sell any common shares under the Sales Agreement, and may at any time suspend solicitation and offers under the Sales Agreement.

 

Our common shares sold under the Sales Agreement will be issued pursuant to our effective shelf registration statement on Form S-3 (File No. 333-235889), including the Prospectus Supplement and the base prospectus included therein, which registration statement was originally filed with the SEC on January 10, 2020 and declared effective by the SEC on June 15, 2020.

 

The legal opinion of Conyers Dill & Pearman Limited relating to our common shares being offered is filed as Exhibit 5.1 to this Current Report on Form 8-K.

 

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any sale of such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.    
     
5.1   Opinion of Conyers Dill & Pearman Limited.
     
23.1   Consent of Conyers Dill & Pearman Limited (included in Exhibit 5.1).
     
104   Cover Page lnteractive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Axovant Gene Therapies Ltd.
     
Date: October 2, 2020 By: /s/ David Nassif
  Name: David Nassif
  Title: Principal Financial Officer and Principal Accounting Officer

 

 

 

EX-5.1 2 tm2031140d2_ex5-1.htm EXHIBIT 5.1

 

Exhibit 5.1

 

 

2 October 2020

 

Matter No.:365849

Doc Ref: 17974095

 

+1 441 278 7957

karoline.tauschke@conyers.com

 

Axovant Gene Therapies Ltd.

Clarendon House

2 Church Street

Hamilton HM 11

Bermuda

 

Dear Sirs,

 

Axovant Gene Therapies Ltd. (the “Company”)

 

We have acted as special legal counsel in Bermuda to the Company in connection with an offering to be made pursuant to the prospectus (the “Prospectus”, which term does not include any other document or agreement whether or not specifically referred to therein or attached as an exhibit or schedule thereto) comprised of a base prospectus included in a registration statement on Form S-3 (File No. 333-235889) (the “Registration Statement”, which term does not include any other document or agreement whether or not specifically referred to therein or attached as an exhibit or schedule thereto) declared effective by the U.S. Securities and Exchange Commission (the “Commission”) on 15 June 2020, as supplemented by the prospectus supplement dated 2 October 2020, relating to the registration under the U.S. Securities Act of 1933, as amended (the “Securities Act”), of that number of the Company’s common shares, par value US$0.00001 each, having an aggregate gross sales price of up to $50,000,000 (“Common Shares”), such Common Shares to be sold through SVB Leerink LLC as sales agent and/or principal of the Company pursuant to a sales agreement dated 11 June 2020 between the Company and SVB Leerink LLC.

 

For the purposes of giving this opinion, we have examined the following documents:

 

(i)the Registration Statement; and

(ii)the Prospectus.

 

We have also reviewed the memorandum of association and the bye-laws of the Company (together, the “Constitutional Documents”), each certified by the Secretary of the Company on 1 October 2020, a copy of minutes of a meeting of the board of directors of the Company on 28 December 2016, and an extract of minutes of a meeting of the board of directors of the Company held on 23 April 2020 certified by the Principal Financial Officer and Principal Accounting Officer of the Company and a written resolution of the pricing committee of the board of directors of the Company passed on 1 October 2020 (collectively, the “Minutes”), and such other documents and made such enquiries as to questions of law as we have deemed necessary in order to render the opinion set forth below.

 

 

 

We have assumed (a) the genuineness and authenticity of all signatures and the conformity to the originals of all copies (whether or not certified) examined by us and the authenticity and completeness of the originals from which such copies were taken; (b) that where a document has been examined by us in draft form, it will be or has been executed and/or filed in the form of that draft, and where a number of drafts of a document have been examined by us all changes thereto have been marked or otherwise drawn to our attention; (c) the accuracy and completeness of all factual representations made in the Registration Statement and the Prospectus, and any other documents reviewed by us; (d) that the resolutions contained in the Minutes were passed at one or more duly convened, constituted and quorate meetings or by unanimous written resolutions, remain in full force and effect and have not been, and will not be, rescinded or amended; (e) that the Constitutional Documents will not be amended in any manner that would affect the opinions expressed herein; (f) that there is no provision of the law of any jurisdiction, other than Bermuda, which would have any implication in relation to the opinions expressed herein; (g) that the Company will have sufficient authorised capital to effect the issue of any of the Common Shares at the time of issuance; (h) that the Company’s Common Shares will be listed on an appointed stock exchange, as defined in the Companies Act 1981, as amended (the “Companies Act”), which includes the NASDAQ, at the time of the issuance of any Common Shares; and (i) that, upon the issue of any Common Shares, the Company will receive consideration for the issue price thereof which shall be equal to at least the par value thereof.

 

We have made no investigation of and express no opinion in relation to the laws of any jurisdiction other than Bermuda. This opinion is to be governed by and construed in accordance with the laws of Bermuda and is limited to and is given on the basis of, the current law and practice in Bermuda. This opinion is issued solely for your benefit and use in connection with the matter described herein and is not to be relied upon by any other person, firm or entity or in respect of any other matter.

 

On the basis of and subject to the foregoing, we are of the opinion that:

 

1.The Company is duly incorporated and existing under the laws of Bermuda in good standing (meaning solely that it has not failed to make any filing with any Bermuda governmental authority or pay any Bermuda government fee or tax which would make it liable to be struck off the Register of Companies and thereby cease to exist under the laws of Bermuda).

 

2.When issued and paid for in accordance with the Registration Statement, the Common Shares to be sold by the Company will be validly issued, fully paid and non-assessable (which term means when used herein that no further sums are required to be paid by the holders thereof in connection with the issue of such Common Shares).

 

2

 

 

We hereby consent to (i) the filing of this opinion as an exhibit to the Company’s Current Report on Form 8-K filed on or about 2 October 2020 for incorporation by reference into the Registration Statement and (ii) the references to our firm under the caption “Legal Matters” in the Registration Statement. In giving this consent, we do not hereby admit that we are experts within the meaning of Section 11 of the Securities Act or that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission promulgated thereunder.

 

Yours faithfully,

 

/s/ Conyers Dill & Pearman Limited

 

Conyers Dill & Pearman Limited

 

3

EX-101.SCH 3 axgt-20201002.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 axgt-20201002_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 axgt-20201002_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2031140d2_ex5-1img001.jpg GRAPHIC begin 644 tm2031140d2_ex5-1img001.jpg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end XML 7 tm2031140d2_8k_htm.xml IDEA: XBRL DOCUMENT 0001636050 2020-10-01 2020-10-02 iso4217:USD shares iso4217:USD shares 0001636050 false 8-K 2020-10-02 Axovant Gene Therapies Ltd. D0 001-37418 98-1333697 Suite 1, 3rd Floor 11-12 St. James’s Square London GB SW1Y 4LB 44 203 997 8931 false false false false Common Shares, $0.00001 par value per share AXGT NASDAQ true true XML 8 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover
Oct. 02, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 02, 2020
Entity File Number 001-37418
Entity Registrant Name Axovant Gene Therapies Ltd.
Entity Central Index Key 0001636050
Entity Tax Identification Number 98-1333697
Entity Incorporation, State or Country Code D0
Entity Address, Address Line One Suite 1, 3rd Floor
Entity Address, Address Line Two 11-12 St. James’s Square
Entity Address, City or Town London
Entity Address, Country GB
Entity Address, Postal Zip Code SW1Y 4LB
Country Region 44
City Area Code 203
Local Phone Number 997 8931
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Shares, $0.00001 par value per share
Trading Symbol AXGT
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period true
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 96 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://axovant.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2031140d2_8k.htm axgt-20201002.xsd axgt-20201002_lab.xml axgt-20201002_pre.xml tm2031140d2_ex5-1.htm http://xbrl.sec.gov/dei/2020-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2031140d2_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "tm2031140d2_8k.htm" ] }, "labelLink": { "local": [ "axgt-20201002_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "axgt-20201002_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "axgt-20201002.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "AXGT", "nsuri": "http://axovant.com/20201002", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "tm2031140d2_8k.htm", "contextRef": "From2020-10-01to2020-10-02", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://axovant.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "tm2031140d2_8k.htm", "contextRef": "From2020-10-01to2020-10-02", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-US": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-US": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://axovant.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 15 0001104659-20-111774-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-20-111774-xbrl.zip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�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end